Contemporary treatment of metastatic renal cell carcinoma

Contemporary treatment of metastatic renal cell carcinoma

The introduction of targeted therapy has revolutionized the treatment of patients with metastatic renal cell carcinoma (mRCC). The current standard of care focuses on the inhibition of angiogenesis through the targeting of the vascular endothelial growth factor receptor (VEGFR) and the mammalian tar...

Full description

Bibliographic Details
Main Authors: Igor Stukalin, Nimira Alimohamed, Daniel Y.C. Heng
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-07-01
Series:Oncology Reviews
Subjects:
Renal cell carcinoma
targeted therapy
immunotherapy
nivolumab
cabozantinib.
Online Access:http://www.oncologyreviews.org/index.php/or/article/view/295

Similar Items

Similar Items